Structured Summary
Abstract
Radiotherapy where cytotoxic radionuclides are linked to antibodies in order to deliver toxins directly to tumor targets. Therapy with targeted radiation rather than antibody-targeted toxins (IMMUNOTOXINS) has the advantage that adjacent tumor cells, which lack the appropriate antigenic determinants, can be destroyed by radiation cross-fire. Radioimmunotherapy is sometimes called targeted radiotherapy, but this latter term can also refer to radionuclides linked to non-immune molecules (see RADIOTHERAPY).
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
MeSH Record
See Also
MeSH Record
Synonyms
3 entry terms
- Immunoradiotherapy
- Immunoradiotherapies
- Radioimmunotherapies
MeSH Record
Aspects Covered
14 allowable subheadings
Indexed with the subheadings adverse effects, classification, economics, ethics, history, instrumentation, methods, mortality, nursing, psychology, standards, statistics & numerical data, trends, veterinary.
MeSH Record
Indexing Annotation
coordinate with disease /radiother
MeSH Record
History Note
92
MeSH Record
Previous Indexing
- Antibodies, Monoclonal/therapeutic use (1984-1991)
- Immunotherapy (1984-1991)
- specific radioisotope/therapeutic use (1981-1991)
MeSH Hierarchy
Tree Numbers
MeSH Record
NLM Classification
QZ 270
AMA Style
References
- National Library of Medicine. Radioimmunotherapy. Medical Subject Headings (MeSH). 2026. Unique ID D016499. http://id.nlm.nih.gov/mesh/2026/D016499
- Radioimmunotherapy. In: Wikipedia. https://en.wikipedia.org/wiki/Radioimmunotherapy
- Radioimmunotherapy. In: Wikidata. https://www.wikidata.org/wiki/Q2126427